Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Non Operating Investment Income (2022 - 2024)

Updated

Crinetics Pharmaceuticals' Non Operating Investment Income came in at -$470,000 for FY2024, compared with -$5.2 million in FY2023.

Analysis

Crinetics Pharmaceuticals (CRNX) Non Operating Investment Income (2022 - 2024) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Investment Income at -$5.2 million in FY2023 and -$1.01 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -470,000.00
Dec 31, 2023 -4.20 Mn
Sep 30, 2023 -997,000.00
Mar 31, 2022 -1.01 Mn
API Access

Crinetics Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CRNX&period=max&api_key=YOUR_API_KEY